« Back
Home /
ALG1001 (Risuteganib)

ALG1001 (Risuteganib)

Item no.	DCC-DC22211-50mg
Manufacturer	DCChemicals
CASRN	1307293-62-4
Amount	50 mg
Quantity options	100 mg 50 mg
Category	Blocking Reagents & Chemicals Molecules
Type	Chemicals
Applications	Blocking
Specific against	other
Smiles	S(C[C@@H](C(N[C@@H]([C@@H](C)O)C(N1CCC[C@H]1C(=O)O)=O)=O)NC(CNC([C@H](CCC/N=C(\N)/N)NC(CN)=O)=O)=O)(=O)(=O)O
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Available
Manufacturer - Applications	ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis; ALG1001 inhibits an integrin-mediated pathway of the vitreoretinal interface, connecting the posterior aspect of the vitreous with the internal limiting membrane of the retina. In blocking this pathway, ALG-1001 helps to achieve vitreous breakdown and separation from the retina.
Molecular Weight	637, 666

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Delivery expected until 11/13/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer